S-7 Surgical Management of Cervical Root Resorption

4 (2 votes)

CE Hours: 1.0

Description

Cervical root resorptions always present with one or several portals of entry. When the size of this or these portals of entry are large and communicate with the alveolar bone, a surgical approach is recommended. It consists in raising a flap, removing the granulation tissue, severing the vascularization in order to stop the progression of the resorptive process, and restoring the dentinal defect. This presentation will address the biological mechanisms of root resorptions and describe step by step the surgical management of cervical root resorptions.

Learning Objectives:  

  • Explain the mechanisms leading to cervical root resorptions
  • Describe when to choose between the internal approach and the surgical management of cervical root resorptions
  • Describe how to surgically manage cervical root resorptions

Key:

Complete
Failed
Available
Locked
S-7 Surgical Management of Cervical Root Resorption
Recorded 05/06/2023  |  60 minutes
Recorded 05/06/2023  |  60 minutes
Evaluation
8 Questions
CE Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Certificate
1.00 CE credit  |  Certificate available
1.00 CE credit  |  Certificate available

Raymond Dionne, D.D.S., M.S. Ph.D.

Dr. Dionne received a DDS from Georgetown University and a PhD from the Medical College of Virginia. He conducted clinical and translational pain research at the National Institute of Dental and Craniofacial Research for 34 years, as well as practiced dentistry part-time in the District of Columbia. He is currently a restless retiree living in Missouri.

Speaker Disclosure

In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: AIM Targeted Therapeutics: Consultant on preclinical development of an investigational analgesic formulation (Ongoing); Rilento Pharma: consultant for pre-clinical development of investigational analgesic formulation (Ongoing)